Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Plasmid DNA for Therapeutic Applications in Cancer.
Martínez-Puente DH, Pérez-Trujillo JJ, Zavala-Flores LM, García-García A, Villanueva-Olivo A, Rodríguez-Rocha H, Valdés J, Saucedo-Cárdenas O, Montes de Oca-Luna R, Loera-Arias MJ. Martínez-Puente DH, et al. Pharmaceutics. 2022 Sep 3;14(9):1861. doi: 10.3390/pharmaceutics14091861. Pharmaceutics. 2022. PMID: 36145609 Free PMC article. Review.
Chronic diseases: Origin and cell mechanisms involved.
Martínez-Puente DH, Rodríguez-Roque CS, Flores-Zavala LM, Pérez-Trujillo JJ, Villanueva-Olivo A, Rodríguez-Rocha H, García-García A, Saucedo-Cárdenas O, Montes De Oca-Luna R, Loera-Arias MJ. Martínez-Puente DH, et al. Cell Mol Biol (Noisy-le-grand). 2023 Dec 31;69(15):26-37. doi: 10.14715/cmb/2023.69.15.5. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 38279502
Enhanced antitumor activity induced by a DNA vaccine encoding E7 antigen fused to an ERAD-targeting sequence.
Martínez-Puente DH, Garza-Morales R, Pérez-Trujillo JJ, Bernabé-Acosta F, Villanueva-Olivo A, García-García A, Zavala-Flores LM, Rodríguez-Rocha H, Valdés J, Saucedo-Cárdenas O, Montes de Oca-Luna R, Loera-Arias MJ. Martínez-Puente DH, et al. J Drug Target. 2023 Jan;31(1):100-108. doi: 10.1080/1061186X.2022.2107651. Epub 2022 Aug 8. J Drug Target. 2023. PMID: 35896308
Targeting E7 antigen to the endoplasmic reticulum degradation pathway promotes a potent therapeutic antitumor effect.
Martínez-Puente DH, Garza-Morales R, Pérez-Trujillo JJ, García-García A, Villanueva-Olivo A, Rodríguez-Rocha H, Zavala-Flores LM, Saucedo-Cárdenas O, Montes de Oca-Luna R, Loera-Arias MJ. Martínez-Puente DH, et al. J Drug Target. 2021 Dec;29(10):1102-1110. doi: 10.1080/1061186X.2021.1919124. Epub 2021 Apr 29. J Drug Target. 2021. PMID: 33926356